Tender detail
Medicines discount agreement for emtricitabine + rilpivirine + tenofovir disoproxil fumarate
Summary
The tender concerns the conclusion of a non-exclusive discount agreement for medicines containing the active substance emtricitabine + rilpivirine + tenofovir disoproxil fumarate, ATC J05AR08. The bidder must take into account that the contract concerns medicines to be specified in Annex 2 to the agreement. The exact qualification and compliance requirements must be checked in the tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.